|
This is an index of adverse event reports related to Accolate (Zafirlukast). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the adverse reaction. Or scroll down to view all available reports.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (6)
Cases resulting in a serious event (6)
Cases resulting in death (1)
Cases resulting in hospitalization (3)
Cases resulting in other serious reactions (3)
Adverse event in 82 year old female receiving Accolate (Zafirlukast)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: 82 year old female, weighing 61.2 kg (134.6 pounds)
Adverse reactions / side effects: Stomach Discomfort, Alopecia, Intraocular Pressure Increased
Suspect drug(s):
Accolate (Zafirlukast)
Adverse event in 6 year old male receiving Accolate (Zafirlukast)
Reported by a health professional (non-physician/pharmacist) from Spain on 2007-10-29
Patient: 6 year old male
Adverse reactions / side effects: Psychomotor Hyperactivity, Disturbance in Attention, Bradyphrenia
Suspect drug(s):
Accolate
Administration route: Oral
Start date: 2007-03-01
End date: 2007-05-01
Pulmicort
Start date: 2007-03-01
Adverse event in female receiving Accolate (Zafirlukast)
Reported by a consumer/non-health professional from United States on 2007-10-26
Patient: female
Adverse reactions / side effects: Intraocular Pressure Increased
Suspect drug(s):
Accolate (Zafirlukast)
Adverse event in 54 year old female receiving Accolate (Zafirlukast)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-06-01
Patient: 54 year old female, weighing 92.7 kg (203.9 pounds)
Adverse reactions / side effects: Pneumonia Fungal, Hepatic Necrosis, Bronchopneumonia, Myocardial Ischaemia, Multi-Organ Failure, Pneumonia Bacterial, Sepsis, Acute Hepatic Failure, Aspergillosis, Diffuse Alveolar Damage, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Accolate (Zafirlukast)
Other drugs received by patient: Synthroid; Zoloft; Advair Diskus 100 / 50; Albuterol; Albuterol; Veetids; Singulair; Azmacort; Azmacort
Adverse event in 36 year old female receiving Accolate (Zafirlukast)
Reported by a individual with unspecified qualification from United States on 2007-04-13
Patient: 36 year old female, weighing 127.0 kg (279.4 pounds)
Adverse reactions / side effects: Overdose, Self Injurious Behaviour, Suicidal Ideation
Adverse event resulted in: hospitalization
Suspect drug(s):
Accolate (Zafirlukast)
Other drugs received by patient: Synthroid; Lereca; Zoloft
Adverse event in 47 year old female receiving Accolate (Zafirlukast)
Reported by a individual with unspecified qualification from Japan on 2007-02-09
Patient: 47 year old female
Adverse reactions / side effects: Productive Cough, Hepatic Function Abnormal, Blood Immunoglobulin A Decreased, Pyrexia, Blood Immunoglobulin G Decreased, Bacteria Sputum Identified, Immunoglobulins Decreased, Gamma-Glutamyltransferase Increased, Interstitial Lung Disease, Cough, Blood Immunoglobulin M Decreased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Eosinophil Count Increased, Eosinophilia, Bronchiectasis, Dysphonia, Aspartate Aminotransferase Increased, Bronchitis, Hypogammaglobulinaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Accolate
Dosage: 20 mg, bid
Administration route: Oral
Indication: Asthma
Start date: 2003-09-01
End date: 2004-03-01
Mucosolvan
Dosage: 45 mg/day
Administration route: Oral
Indication: Bronchiectasis
Start date: 2003-09-01
End date: 2004-08-01
Tegretol
Dosage: 200 mg, bid
Administration route: Oral
Indication: Epilepsy
Start date: 2002-05-13
End date: 2004-10-26
Tegretol
Dosage: 200 mg/day
Administration route: Oral
Start date: 2004-10-27
End date: 2004-11-10
Tegretol
Dosage: 200 mg/day
Administration route: Oral
Start date: 2002-05-02
End date: 2002-05-12
Theo-DUR
Dosage: 100 mg, qid
Administration route: Oral
Indication: Asthma
Start date: 2003-09-01
End date: 2004-03-01
|
